ISSN: 1743-5889

Journal Home

Journal Guideline

Nanomedicine Q2 Unclaimed

Taylor and Francis Ltd. United Kingdom

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Nanomedicine is a journal indexed in SJR in Medicine (miscellaneous) and Development with an H index of 141. It has an SJR impact factor of 0,572 and it has a best quartile of Q2. It has an SJR impact factor of 0,572.

Type: Journal

Type of Copyright:

Languages:

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Biomedical Engineering (Q2) Development (Q2) Materials Science (miscellaneous) (Q2) Medicine (miscellaneous) (Q2) Nanoscience and Nanotechnology (Q2) Bioengineering (Q3)

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

0,572

SJR Impact factor

141

H Index

186

Total Docs (Last Year)

488

Total Docs (3 years)

12296

Total Refs

1610

Total Cites (3 years)

433

Citable Docs (3 years)

3.44

Cites/Doc (2 years)

66.11

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Clinical and Translational Oncology Q2
Neuro-Oncology Practice Q2
Revista de Saude Publica Q2
Human Vaccines and Immunotherapeutics Q2
British Journal of Nutrition Q2

Compare this journals

Aims and Scope

Best articles by citations

Nanostructured titanium: the ideal material for improving orthopedic implant efficacy?

Biomedical applications of gold nanomaterials

Mucoadhesive nanogels by ionotropic crosslinking of chitosan-g-oligo(NiPAam) polymeric micelles as novel drug nanocarriers

Highlights from the latest articles in gold nanoparticles for theranostics

Nanotargeted agents: an emerging therapeutic strategy for breast cancer

Colloidal nanomaterial-based immunoassay

PLGA nanoparticles with CD133 aptamers for targeted delivery and sustained release of propranolol to hemangioma

Nanoparticle aerosols: boon or bane for breathing?

Targeted nanomedicines: effective treatment modalities for cancer, AIDS and brain disorders

Novel surface-engineered solid lipid nanoparticles of rosuvastatin calcium for low-density lipoprotein-receptor targeting: a Quality by Design-driven perspective

Molecular plasmonics for biology and nanomedicine

Conjugation of functionalized gadolinium metallofullerenes with IL-13 peptides for targeting and imaging glial tumors

SHOW MORE ARTICLES

Research Highlights

Amphiphilic curcumin conjugate-forming nanoparticles as anticancer prodrug and drug carriers:in vitroandin vivoeffects

Molecular basis of the mucosal immune system: from fundamental concepts to advances in liposome-based vaccines

Nanotechnology in bladder cancer: current state of development and clinical practice

The rise and rise of stealth nanocarriers for cancer therapy: passive versus active targeting

Functionalization of iron oxide magnetic nanoparticles with targeting ligands: their physicochemical properties andin vivobehavior

Targeted removal of migratory tumor cells by functionalized magnetic nanoparticles impedes metastasis and tumor progression

Research Highlights

Graphene oxide coatings prevent Candida albicans biofilm formation with a controlled release of curcumin-loaded nanocomposites

Research Highlights

Transferrin-mediated targeting of bacteriophage HK97 nanoparticles into tumor cells

Research Highlights

Nanomedicine Q2 Unclaimed

- €

NPD

- €

Metrics

0,572

141

186

488

12296

1610

433

3.44

66.11

Comments

Other journals with similar parameters

Aims and Scope

Best articles by citations

FAQS

What is the impact factor of Nanomedicine?